SCHEMBL4528233

SCHEMBL4528233

C#CC(C)(C)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.52
TAAR1 Q96RJ0 1/20 0.52
LMNA P02545 3/20 0.48
CYP2D6 P10635 2/20 0.48
TRPA1 O75762 1/20 0.42
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 3/20 0.39
TSHR P16473 2/20 0.39
USP2 O75604 1/20 0.39
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
PYCR1 P32322 1/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.38
FDPS P14324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9810146 0.80 SLC6A2 (0.50) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL21315397 0.78 ESR1 (0.39) SLC6A2TSHRBLM
SCHEMBL10348475 0.78 SLC6A2 (0.59) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL5784144 0.77 SLC6A2 (0.52) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL96456 0.77 SLC6A2 (0.52) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL11287682 0.74 SLC6A2 (0.44) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL350845 0.74 TSHR (0.50) SLC6A2TAAR1TSHRSMN1; SMN2ALDH1A1
SCHEMBL28756083 0.73 CYP1A2 (0.50) SLC6A2TAAR1LMNACYP2D6TRPA1
SCHEMBL3395923 0.73 TAAR1 (0.52) SLC6A2TAAR1LMNACYP2D6CYP1A2
SCHEMBL347187 0.72 SLC6A2 (0.64) SLC6A2TAAR1LMNACYP2D6TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162994-A1 6,6'-Bis-(1-Phosphanorbornadiene) diphosphines, their preparation and their uses MATHEY FRANCOIS (FR) 2003-08-28 US claimed
US-6521795-B2 Minimizing formation of enantiomer with use of catalyst comprising transition metals with chiral ligands RHODIA CHIMIE (FR) 2003-02-18 US claimed
US-20020042540-A1 New 6,6'-bis-(1-phosphanorbornadiene) diphosphines, their preparation and their uses MATHEY FRANCOIS (FR) 2002-04-11 US claimed
US-6288279-B1 THEIR PREPARATION PROCESS AND THEIR USE IN ASYMMETRICAL CATALYSIS. REARRANGING A DIPHOSPHOLE, REACTING THE DIPHOSPHOLE WITH AN ACETYLENIC COMPOUND TO FORM THE DIPHOSPHINE RHODIA CHIMIE (FR) 2001-09-11 US claimed
JP-2001513805-A 2001-09-04 JP claimed
EP-0968220-A1 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES RHODIA CHIMIE (FR) 2000-01-05 EP claimed
WO-1998039345-A1 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES RHODIA CHIMIE (FR) 1998-09-11 WO claimed
US-12275813-B2 Polymerizable composition for optical materials and application of same MITSUI CHEMICALS, INC. (JP) 2025-04-15 US disclosed
EP-3308928-B1 METHOD FOR PRODUCING PLASTIC LENS AND USE OF A DEVICE FOR PRODUCING A PLASTIC LENS MITSUI CHEMICALS INC (JP) 2025-03-05 EP disclosed
EP-3527597-B1 POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, AND USE THEREOF MITSUI CHEMICALS INC (JP) 2024-08-07 EP disclosed
US-11639413-B2 Polymerizable composition for optical materials and application of same MITSUI CHEMICALS, INC. (JP) 2023-05-02 US disclosed
CN-111868099-B Method for setting polymerization conditions and method for producing optical material 三井化学株式会社 2022-12-16 CN disclosed
EP-3594288-B1 POLYMERIZABLE COMPOSITION AND MOLDED BODY MITSUI CHEMICALS INC (JP) 2022-11-16 EP disclosed
US-20030162994-A1 6,6'-Bis-(1-Phosphanorbornadiene) diphosphines, their preparation and their uses MATHEY FRANCOIS (FR) 2003-08-28 US disclosed
US-6521795-B2 Minimizing formation of enantiomer with use of catalyst comprising transition metals with chiral ligands RHODIA CHIMIE (FR) 2003-02-18 US disclosed
US-20020042540-A1 New 6,6'-bis-(1-phosphanorbornadiene) diphosphines, their preparation and their uses MATHEY FRANCOIS (FR) 2002-04-11 US disclosed
US-6288279-B1 THEIR PREPARATION PROCESS AND THEIR USE IN ASYMMETRICAL CATALYSIS. REARRANGING A DIPHOSPHOLE, REACTING THE DIPHOSPHOLE WITH AN ACETYLENIC COMPOUND TO FORM THE DIPHOSPHINE RHODIA CHIMIE (FR) 2001-09-11 US disclosed
EP-0968220-A1 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES RHODIA CHIMIE (FR) 2000-01-05 EP disclosed
WO-1998039345-A1 6,6'-BIS-(1-PHOSPHANORBORNADIENE) DIPHOSPHINES RHODIA CHIMIE (FR) 1998-09-11 WO disclosed
US-4427595-A Catalyst composition to effect metathesis of acetylenes MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1984-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042540-A1 New 6,6'-bis-(1-phosphanorbornadiene) diphosphines, their preparation and their uses PHOSPHO1, DUS2, DCPS SLC6A2 4657/4885TAAR1 3199/4885LMNA 4461/4885
US-20030162994-A1 6,6'-Bis-(1-Phosphanorbornadiene) diphosphines, their preparation and their uses DUS2, PHOSPHO1, DCPS SLC6A2 4597/4885TAAR1 3300/4885LMNA 4375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.